GL1X · GenesisL1 explorer

MolNFT v1 · #99549 · protein

Identification of amides derived from 1H-PYRAZOLO[3,4-B]PYRIDINE-5- carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (nampt)

4M6P: “Identification of amides derived from 1H-PYRAZOLO[3,4-B]PYRIDINE-5- carboxylic acid as potent inhibitors of…”. X-ray diffraction, 2 ligands (20R, PO4), 8 pockets (best druggability 0.80). MolNFT v1 #99549 on GenesisL1: 3D structure…

PDB
4M6P
Type
protein
Length
943 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nicotinamide phosphoribosyltransferase
EC
2.4.2.12
UniProt
P43490
Ligands
20R, PO4
Pockets
8 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein47242% helix, 19% strandP43490
BNicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein47142% helix, 18% strandP43490

Ligands and binding sites

  • 20R · N-[4-(phenylsulfonyl)benzyl]-2H-pyrazolo[3,4-b]pyridine-5-carboxamide · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17530.800.848220R, PO4
27200.800.8477PO4, 20R
37010.730.7958empty
4780.350.7618empty
5830.350.7517empty

Interfaces

1 interface between chains.

  • A–B · 4262 Ų buried · 79 hydrogen bonds · protein-protein

Compared structures

  • 4M6P · Identification of Amides Derived From 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic Acid as… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.